hidesy-shutterstock-com-1

hidesy / Shutterstock.com

24 September 2015Big PharmaAnja Lunze and Paul England

SPCs: When a few days makes a difference

On September 10, Advocate-General (AG) Niilo Jääskinen delivered his opinion in a case concerning supplementary protection certificates (SPCs). The case (C-471/14) was brought by Seattle Genetics against the Austrian Patent Office (APO).

Already registered?

Login to your account

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk

More features

Attorney v examiner: Navigating patenting's AI tools ‘arms race’

Lewis Roca promotes tech expert to managing partner

US targets ‘product hopping’ with biologic litigation curbs

UPC confirms validity of Edwards Lifesciences heart valve tech patent

‘Don’t stifle UK AI innovation’: King's speech on AI Act prompts warnings

Novo Nordisk’s uphill battle in the counterfeit weight loss craze

Most active firms at UPC revealed in report on court’s first year

FTC supports USPTO terminal disclaimer plan amid opposition